ORCID as entered in ROS

Select Publications
2010, 'Drug trafficking: Time to abolish the death penalty', Suchtmedizin in Forschung Und Praxis, 12, pp. 115 - 116
,2010, 'The contribution of injecting drug users in Sydney, Melbourne and Brisbane to rising benzodiazepine use in Australia 2000 to 2006', Australian and New Zealand Journal of Public Health, 34, pp. 315 - 319, http://dx.doi.org/10.1111/j.1753-6405.2010.00533.x
,2010, 'The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007', Addiction, 105, pp. 1071 - 1079, http://dx.doi.org/10.1111/j.1360-0443.2010.02903.x
,2010, 'Anticipating the use of life extension technologies', EMBO Reports, 11, pp. 334 - 338, http://dx.doi.org/10.1038/embor.2010.48
,2010, 'The need for more explanatory humility in addiction neurobiology: Commentaries on Kalant (2010)', Addiction, 105, pp. 790 - 791, http://dx.doi.org/10.1111/j.1360-0443.2009.02783.x
,2010, 'Patterns of antipsychotic medication use in Australia 20022007', Australian and New Zealand Journal of Psychiatry, 44, pp. 372 - 377, http://dx.doi.org/10.3109/00048670903489890
,2010, 'Smokeless tobacco products: Unrecognised regulatory and policy opportunities', Drug and Alcohol Review, 29, pp. 119 - 120, http://dx.doi.org/10.1111/j.1465-3362.2010.00170.x
,2010, 'Testing for cannabis in the work-place: A review of the evidence', Addiction, 105, pp. 408 - 416, http://dx.doi.org/10.1111/j.1360-0443.2009.02808.x
,2010, 'Why we need tobacco sales data for good tobacco control', Medical Journal of Australia, 192, pp. 3 - 4, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03389.x
,2010, 'A cautionary bibliometric tale of two cities', Scientometrics, 84, pp. 317 - 320, http://dx.doi.org/10.1007/s11192-009-0118-7
,2010, 'Are Australian smokers interested in using low-nitrosamine smokeless tobacco for harm reduction?', Tobacco Control, 19, pp. 451 - 456, http://dx.doi.org/10.1136/tc.2009.033670
,2010, 'Beyond the right to injectable heroin', AJOB Neuroscience, 1, pp. 48 - 49, http://dx.doi.org/10.1080/21507740903504467
,2010, 'Drug trafficking: Time to abolish the death penalty', Exartisis, 2010, pp. 101 - 107
,2010, 'Harm reduction policies for tobacco users', International Journal of Drug Policy, 21, pp. 129 - 130, http://dx.doi.org/10.1016/j.drugpo.2009.10.008
,2010, 'Alcohol policy reform in Australia: What can we learn from the evidence?', MJA Open, 192, pp. 468 - 470
,2010, 'Weak evidence for large claims contribute to the phantom debate Response', BIOSOCIETIES, 5, pp. 482 - 483, http://dx.doi.org/10.1057/biosoc.2010.31
,2009, 'Clashes between the government and its expert advisers', BMJ Online, 339, pp. 1095, http://dx.doi.org/10.1136/bmj.b4662
,2009, 'Ethical concerns in the community about technologies to extend human life span', American Journal of Bioethics, 9, pp. 68 - 76, http://dx.doi.org/10.1080/15265160903318368
,2009, 'Direct-to-consumer genome-wide scans: Astrologicogenomics or simple scams?', American Journal of Bioethics, 9, pp. 54 - 56, http://dx.doi.org/10.1080/15265160902894021
,2009, 'Drug trafficking: Time to abolish the death penalty', Journal of Groups in Addiction and Recovery, 4, pp. 322 - 326, http://dx.doi.org/10.1080/15560350903340981
,2009, 'Ethical, social, and personal implications of extended human lifespan identified by members of the public', Rejuvenation Research, 12, pp. 351 - 357, http://dx.doi.org/10.1089/rej.2009.0907
,2009, 'Reprint of "Understanding comorbidity between substance use, anxiety and affective disorders: Broadening the research base"', Addictive Behaviors, 34, pp. 795 - 799, http://dx.doi.org/10.1016/j.addbeh.2009.03.040
,2009, 'Policy forum', Drugs and Alcohol Today, 9, pp. 11 - 14, http://dx.doi.org/10.1108/17459265200900024
,2009, 'The potential role of snus in tobacco harm reduction', Addiction, 104, pp. 1586 - 1587, http://dx.doi.org/10.1111/j.1360-0443.2009.02706.x
,2009, 'Editorial: Drug trafficking: Time to abolish the death penalty', Addiction, 104, pp. 1267 - 1269, http://dx.doi.org/10.1111/j.1360-0443.2009.02625.x
,2009, 'Predicting the future prevalence of cigarette smoking in Australia: How low can we go and by when?', Tobacco Control, 18, pp. 183 - 189, http://dx.doi.org/10.1136/tc.2008.027615
,2009, 'Understanding comorbidity between substance use, anxiety and affective disorders: Broadening the research base', Addictive Behaviors, 34, pp. 526 - 530, http://dx.doi.org/10.1016/j.addbeh.2009.03.010
,2009, 'Sociodemographic correlates of antidepressant utilisation in Australia', Medical Journal of Australia, 190, pp. 479 - 483, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02522.x
,2009, 'Scare-mongering and the anticipatory ethics of experimental technologies', American Journal of Bioethics, 9, pp. 47 - 48, http://dx.doi.org/10.1080/15265160902788736
,2009, 'Smokeless tobacco use in Australia', Drug and Alcohol Review, 28, pp. 284 - 291, http://dx.doi.org/10.1111/j.1465-3362.2009.00058.x
,2009, 'The challenges in developing a rational cannabis policy', Current Opinion in Psychiatry, 22, pp. 258 - 262, http://dx.doi.org/10.1097/YCO.0b013e3283298f36
,2009, 'The "alcopops" tax: Heading in the right direction', Medical Journal of Australia, 190, pp. 294 - 295, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02415.x
,2009, 'Challenges in reducing cannabis-related harm in Australia', Drug and Alcohol Review, 28, pp. 110 - 116, http://dx.doi.org/10.1111/j.1465-3362.2008.00039.x
,2009, 'Supping with the Devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products', Public Health, 123, pp. 287 - 291, http://dx.doi.org/10.1016/j.puhe.2008.12.018
,2009, 'Systematic review of interventions to improve prescribing', Annals of Pharmacotherapy, 43, pp. 502 - 513, http://dx.doi.org/10.1345/aph.1L488
,2009, 'Community perceptions on the significant extension of life: An exploratory study among urban adults in Brisbane, Australia', Social Science and Medicine, 68, pp. 496 - 503, http://dx.doi.org/10.1016/j.socscimed.2008.11.002
,2009, 'Proinsulin peptide immunotherapy in type 1 diabetes: Report of a first-in-man Phase I safety study', Clinical and Experimental Immunology, 155, pp. 156 - 165, http://dx.doi.org/10.1111/j.1365-2249.2008.03814.x
,2009, 'Anticipating the anti-ageing pill. Lessons from the history of the oral contraceptive pill and hormone replacement therapy', EMBO Reports, 10, pp. 108 - 113, http://dx.doi.org/10.1038/embor.2008.251
,2009, 'Cannabis use in Canada: The need for a 'Public Health' approach', Canadian Journal of Public Health, 100, pp. 101 - 103, http://dx.doi.org/10.1007/bf03405515
,2009, 'Handel med narkotika: Dags att avskaffa dödsstraffet', NAD Nordic Studies on Alcohol and Drugs, 26, pp. 337 - 340, http://dx.doi.org/10.1177/145507250802600505
,2009, 'Mapping community concerns about radical extensions of human life expectancy', American Journal of Bioethics, 9, pp. W4 - W5, http://dx.doi.org/10.1080/15265160903316446
,2009, 'Multiple genetic tests for susceptibility to smoking do not outperform simple family history', Addiction, 104, pp. 118 - 126, http://dx.doi.org/10.1111/j.1360-0443.2008.02392.x
,2009, 'Professional and personal attitudes of researchers in ageing towards life extension', Biogerontology, 10, pp. 73 - 81, http://dx.doi.org/10.1007/s10522-008-9149-3
,2009, 'The adverse health effects of cannabis use: What are they, and what are their implications for policy?', International Journal of Drug Policy, 20, pp. 458 - 466, http://dx.doi.org/10.1016/j.drugpo.2009.02.013
,2009, '[Commentary] THE POTENTIAL ROLE OF SNUS IN TOBACCO HARM REDUCTION', ADDICTION, 104, pp. 1586 - 1587
,2009, 'Adverse health effects of non-medical cannabis use', Lancet, 374, pp. 1383 - 1391, http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61037-0/abstract
,2009, 'Alcohol industry and government revenue derived from underage drinking by Australian adolescents 2005', Addictive Behaviors, 34, pp. 75 - 81
,2009, 'Estimating the burden of disease attributable to illicit drug use and mental disorders: What is `Global Burden of Disease 2005` and why does it matter?', Addiction, 104, pp. 1466 - 1471
,2009, 'Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention', Addiction, 104, pp. 1363 - 1372, http://dx.doi.org/10.1111/j.1360-0443.2009.02633.x
,2009, 'Should burden of disease estimates include cannabis use as a risk factor for psychosis?', PLOS Medicine, 6, pp. e1000133 - e1000133, http://dx.doi.org/10.1371/journal.pmed.1000133
,